Narrativa CSR Atlas for Clinical Trials Reports Automation
How Insud Pharma accelerates clinical trials with Narrativa’s CSR Atlas
Insud Pharma, one of the leading pharmaceutical companies globally, is transforming its approach to clinical trial documentation through an ambitious partnership with Narrativa. By integrating cutting-edge Generative AI, the two companies aim to streamline regulatory content creation—accelerating time to market, improving document quality, and reducing operational complexity.
From data to regulatory submission
Clinical trial documentation is one of the most labor-intensive aspects of drug development. Patient narratives, Clinical Study Reports (CSRs), and Tables, Listings, and Figures (TLFs) often involve massive volumes of structured data and painstaking manual effort from medical writing teams.
To tackle this challenge, Insud Pharma has adopted Narrativa’s AI-powered Medical Writing Platform, a proprietary solution that transforms clinical data directly into regulatory-ready documents.
How the platform works
Narrativa’s platform combines Generative AI models with a proprietary Knowledge Graph, ensuring accurate, traceable, and regulator-ready content generation. The AI is configured to align with each sponsor’s documentation standards, enabling:
- Patient Narratives
- CSRs
- TLFs
- Redaction & Anonymization
Medical writers receive high-quality first drafts, freeing them to focus on quality control, final review, and strategic input.
The impact: simpler, smarter, faster clinical trials
With this implementation, Insud Pharma is set to unlock a range of powerful benefits:
- Faster approvals
- Initial drafts delivered in hours instead of weeks accelerate the clinical trial timeline.
- Lower risk
- Automated data interpretation reduces human error and improves regulatory compliance.
- Cost efficiency
- Fewer manual hours translate to leaner operations and reduced overhead.
- Operational simplicity
- Automation minimizes the number of stakeholders involved—streamlining collaboration and version control.
A shared vision for global health
Backed by over 45 years of pharmaceutical leadership and a presence in more than 50 countries, Insud Pharma’s mission is to improve access to quality medicines. Partnering with Narrativa aligns with their focus on R&D innovation and commitment to delivering treatments to patients faster, safer, and at a lower cost.
This collaboration is not just about speeding up paperwork—it’s about enabling life-saving solutions to reach those who need them most.
